Key Points
- CEO Thomas David Hull III sold 2,177 shares of Kewaunee Scientific on Jan. 7 at an average price of $37.50 (proceeds $81,637.50) as part of a series of insider sales totaling 4,719 shares worth roughly $179,000 between Dec. 22 and Jan. 7.
- Following the sale Hull still owns 33,000 shares (a 6.19% reduction, valued at about $1.24 million), while the company trades with a P/E of 9.43, market cap of $106.65 million and a consensus analyst rating of Hold.
Kewaunee Scientific Corporation (NASDAQ:KEQU - Get Free Report) CEO Thomas David Hull III sold 2,177 shares of Kewaunee Scientific stock in a transaction dated Wednesday, January 7th. The shares were sold at an average price of $37.50, for a total transaction of $81,637.50. Following the sale, the chief executive officer owned 33,000 shares in the company, valued at approximately $1,237,500. This represents a 6.19% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.
Thomas David Hull III also recently made the following trade(s):
- On Wednesday, December 31st, Thomas David Hull III sold 629 shares of Kewaunee Scientific stock. The stock was sold at an average price of $37.66, for a total transaction of $23,688.14.
- On Tuesday, December 30th, Thomas David Hull III sold 29 shares of Kewaunee Scientific stock. The stock was sold at an average price of $38.00, for a total value of $1,102.00.
- On Monday, December 29th, Thomas David Hull III sold 884 shares of Kewaunee Scientific stock. The shares were sold at an average price of $38.01, for a total transaction of $33,600.84.
- On Monday, December 22nd, Thomas David Hull III sold 1,000 shares of Kewaunee Scientific stock. The stock was sold at an average price of $39.00, for a total transaction of $39,000.00.
Kewaunee Scientific Stock Performance
Shares of NASDAQ KEQU opened at $37.16 on Friday. The company has a debt-to-equity ratio of 0.81, a current ratio of 2.48 and a quick ratio of 1.71. The company has a market capitalization of $106.65 million, a P/E ratio of 9.43 and a beta of 0.55. Kewaunee Scientific Corporation has a one year low of $30.33 and a one year high of $71.33. The business's 50-day moving average price is $39.00 and its two-hundred day moving average price is $46.88.
Kewaunee Scientific (NASDAQ:KEQU - Get Free Report) last issued its quarterly earnings data on Wednesday, December 10th. The technology company reported $0.91 earnings per share for the quarter. Kewaunee Scientific had a net margin of 4.11% and a return on equity of 22.39%. The business had revenue of $70.10 million during the quarter. During the same quarter in the previous year, the firm posted $1.01 earnings per share.
Hedge Funds Weigh In On Kewaunee Scientific
A number of hedge funds have recently bought and sold shares of the business. Susquehanna International Group LLP acquired a new position in Kewaunee Scientific in the third quarter valued at about $713,000. Punch & Associates Investment Management Inc. grew its stake in Kewaunee Scientific by 61.9% during the third quarter. Punch & Associates Investment Management Inc. now owns 70,085 shares of the technology company's stock worth $2,989,000 after buying an additional 26,785 shares in the last quarter. Mink Brook Asset Management LLC increased its holdings in Kewaunee Scientific by 83.4% in the 3rd quarter. Mink Brook Asset Management LLC now owns 11,571 shares of the technology company's stock valued at $494,000 after buying an additional 5,261 shares during the period. Minerva Advisors LLC boosted its position in shares of Kewaunee Scientific by 3.7% during the 3rd quarter. Minerva Advisors LLC now owns 80,274 shares of the technology company's stock worth $3,424,000 after acquiring an additional 2,832 shares in the last quarter. Finally, Royce & Associates LP bought a new position in Kewaunee Scientific in the third quarter valued at approximately $1,663,000. 32.69% of the stock is owned by institutional investors.
Analyst Upgrades and Downgrades
Several analysts have recently commented on the stock. Wall Street Zen cut shares of Kewaunee Scientific from a "buy" rating to a "hold" rating in a research note on Saturday, December 13th. Weiss Ratings reaffirmed a "hold (c+)" rating on shares of Kewaunee Scientific in a research report on Wednesday, October 8th. One research analyst has rated the stock with a Hold rating, Based on data from MarketBeat.com, the company presently has a consensus rating of "Hold".
Read Our Latest Stock Report on Kewaunee Scientific
About Kewaunee Scientific
(
Get Free Report)
Kewaunee Scientific Corporation (NASDAQ:KEQU) is a global designer and manufacturer of scientific laboratory furniture, casework, fume hoods, containment solutions and related equipment. With roots dating back more than a century, the company develops integrated lab environments for research facilities, universities, biopharma companies, healthcare providers and government laboratories. Its product portfolio encompasses modular and custom casework, workstations, shelving systems, steel and epoxy resin solutions, as well as advanced ventilation and water management systems.
The company operates primary manufacturing facilities in Fitchburg, Wisconsin, supported by regional distribution and service centers in North America, Europe and Asia.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
